Problem

Secrecy about pharmaceutical products

Other Names:
Lack of public access to information on medicines
Incidence:
In the UK, it is a criminal offence for official involved in the licensing or withdrawal of a drug to disclose any information about heir decision. Although the manufacturers of drugs are required to produce data sheets hat identify likely side-effects, there is no public right of access to these safety studies.
Problem Type:
F: Fuzzy exceptional problems
Related UN Sustainable Development Goals:
GOAL 10: Reduced InequalityGOAL 12: Responsible Consumption and Production
Date of last update
07.02.1999 – 00:00 CET